A rare Guillain-Barré syndrome recurrence caused nausea with no motor symptoms but was treated successfully with intravenous ...

GC Biopharma USA, Inc., a leader in plasma-derived products, announced the presentation of new data on the viscosity of several commercially available 10% intravenous immunoglobulin (IVIG) products at ...

The intravenous immunoglobulin (IVIG) market is experiencing significant growth due to the rising prevalence of autoimmune diseases, immune deficiencies, and neurological disorders. Advancements ...

Intravenous Immunoglobulin Likely More Effective Than Corticosteroids in Chronic Inflammatory Demyelinating Polyneuropathy. S. Andrew Josephson, MD. Disclosures. AccessMedicine from McGraw-Hill .

The Intravenous Immunoglobulin market has experienced remarkable growth over recent years, driven by advancements in medical technologies, increasing awareness of immune-related disorders, and rising ...

Treatment options for chronic inflammatory demyelinating polyneuropathy include intravenous immunoglobulin, corticosteroids, plasmapheresis (plasma exchange), and a newer medication called Vyvgart ...

A team of physicians recently reported the successful treatment of refractory autoimmune neuropathies through the infusion of autologous anti-CD19 CAR T-cells.

More About the Study. The study did not compare “005” – as its makers sometimes refer to the drug in shorthand – to treatment with intravenous immunoglobulin, or plasma exchange, another ...